ALEXION PHARMACEUTICALS, INC.

Lobbying client. Federal LDA filings.

Connected on the graph

Inbound (14)

date	from	type	amount	source
—	Zachary Williams	lobbied_for	—	lda_lobbyist_client
—	Jerry Driscoll	lobbied_for	—	lda_lobbyist_client
—	Debra Dixon	lobbied_for	—	lda_lobbyist_client
—	Michael Alexander Williams	lobbied_for	—	lda_lobbyist_client
—	Elizabeth Greer	lobbied_for	—	lda_lobbyist_client
—	Cynthia Brown	lobbied_for	—	lda_lobbyist_client
—	Mark Williams	lobbied_for	—	lda_lobbyist_client
—	Cristina Antelo	lobbied_for	—	lda_lobbyist_client
—	Derrick M White	lobbied_for	—	lda_lobbyist_client
—	Zachary Benjamin Friend	lobbied_for	—	lda_lobbyist_client
—	Michael Taggart	lobbied_for	—	lda_lobbyist_client
—	Jeffrey Forbes	lobbied_for	—	lda_lobbyist_client
2026-01-01	FORBES-TATE	lobbies_for	$50,000	lda_filing
2026-01-01	FEROX STRATEGIES	lobbies_for	$60,000	lda_filing

Source id: 213126
General description: Rare Disease Pharmaceutical company.
State: MA
Country: US
Principal place of business: US
Government-entity client: false
Effective date: 2021-12-01
Total spend (across 1 ingested filings): $60,000

Filings

Posted	Type	Year	Lobbying firm	Income
2026-04-17	`Q1`	2026	FEROX STRATEGIES	$60,000

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.